ReviewPharmaceutics2021

New Perspectives of Gene Therapy on Polyglutamine Spinocerebellar Ataxias: From Molecular Targets to Novel Nanovectors.

Fabiola V Borbolla-Jiménez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.